Innate Pharma announces its turnover for the first nine months of 2010 and updates on its cash situation

Innate Pharma (the “Company” - Euronext Paris: FR0010331421 – IPH) announces a turnover of 0.2 millions euros (210 thousand euros) for the first nine months of 2010, compared with 2.8 million euros (2,776 thousand euros) for the same period in 2009.

Cash, cash equivalents and current financial instruments of the Company amounted to 38.6 million euros as at September 30, 2010.